← All organizations

Pharmacosmos

For profitContributed to NMEWebsite ↗

Also known as: PHARMACOSMOS | Pharmacosmos A/S | PHARMACOSMOS AS | Pharmacosmos A/S, Roervangsvej 30, DK 4300 Holbaek, Denemark | Pharmacosmos Therapeutics, Inc. | Pharmacosmos UK Ltd

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

First NDA

Last known activity

Oct 31, 2025

Timeline

1960s

Jun 1, 1965
Pharmacosmos— Founded

2020s

Jan 16, 2020
ferric derisomaltose— NDA Organization
Jan 16, 2020
ferric derisomaltose— NDA Secondary Org
Feb 12, 2021
trilaciclib— Marketing Organization
Nov 13, 2021
Abfero Pharmaceuticals, Inc— Acquired

Drugs by trial phase (14 distinct, 46 trials)

Phase 4 (8 own, 0 via acquisition)

Phase 3 (5 own, 0 via acquisition)

Phase 2 (0 own, 1 via acquisition)

sp-420

Marketed drugs (2)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Abfero Pharmaceuticals, Inc

Recent trials (50)

NCT06884280CollaboratorPhase 3Oct 31, 2025
NCT06929806Lead sponsorPhase 3May 1, 2025
NCT06929806OfficialPhase 3May 1, 2025
NCT05693909Lead sponsorPhase 2Sep 4, 2023
NCT05693909Study directorPhase 2Sep 4, 2023
NCT05714007CollaboratorPhase 4Aug 31, 2023
NCT05179226Lead sponsorPhase 3Nov 28, 2022
NCT05545202Lead sponsorPhase 4Nov 7, 2022
NCT05258825CollaboratorPhase 4Nov 1, 2022
NCT05467319CollaboratorPhase 3Sep 30, 2022
NCT05304442CollaboratorPhase 3Sep 30, 2022
NCT04945707CollaboratorPhase 4Oct 1, 2021
NCT04913649CollaboratorPhase 4Sep 23, 2021
NCT04608539CollaboratorPhase 4Jan 1, 2021
NCT03466983Lead sponsorPhase 4May 23, 2018

Details

Founded: Holbaek, DK Jun 1, 1965
First NDA: Jan 16, 2020
Last known activity: Oct 31, 2025